CNS Factor

CNS Factor

$40.30
RV105

CNS Factor / NeuroFactor is a practitioner-only listed medicine formulated with selected traditional Chinese medicine ingredients, including Schisandra chinensis. It is intended for qualified healthcare practitioners seeking support for mental concentration, focus, clarity, mental endurance and traditional adaptogen-style stress support.

120 x 500 mg capsules | AUST L 319900

Each 500 mg capsule contains:

Dimocarpus longan fruit dry extract 111 mg
Equivalent to dry fruit 666 mg
Extract ratio 6:1

Dioscorea japonica root dry extract 111 mg
Equivalent to dry root 666 mg
Extract ratio 6:1

Houttuynia cordata herb top dry extract 111 mg
Equivalent to dry herb top 666 mg
Extract ratio 6:1

Schisandra chinensis fruit dry extract 167 mg
Equivalent to dry fruit 5.845 g
Extract ratio 35:1
Extraction solvent: ethanol 80%, purified water 20%

Traditionally used in Chinese medicine to:

  • help the body adapt to stress

Also formulated to:

  • maintain / support mental concentration
  • maintain / support mental focus
  • maintain / support mental clarity
  • maintain / support mental endurance
  • maintain / support mental stamina

Directions

Recommended practitioner dosage:

Take 1 capsule once or twice daily, or as directed by a qualified healthcare practitioner.

Maximum daily dose: 2 capsules daily.

Dosage and duration should be determined by the treating healthcare practitioner based on individual assessment and must not exceed the ARTG-listed maximum daily dose.

This section is provided for qualified healthcare practitioners as professional education. It summarises selected ingredient-level, pathway-level and traditional-use research. It does not represent additional ARTG indications for CNS Factor / NeuroFactor.

CNS Factor / NeuroFactor is relevant to practitioners interested in mental focus, mental clarity, mental endurance, stress adaptation and neurocognitive pathway research.

The formula contains Schisandra chinensis, a traditional Chinese medicine ingredient widely discussed in professional literature in relation to adaptogen-style support, antioxidant pathways, inflammatory signalling, neuroprotective mechanisms and neurocognitive research. Recent review literature has discussed Schisandra lignans in relation to pharmacological mechanisms, antioxidant activity, inflammatory pathways, neuroprotective effects, pharmacokinetics and drug-metabolism considerations.

Schisandra chinensis has also been discussed in preclinical research relating to neuronal resilience, synaptic plasticity and BDNF-related signalling. This provides ingredient-level education around neurocognitive pathway research, but it should not be interpreted as a claim that CNS Factor / NeuroFactor increases BDNF in humans or treats cognitive impairment, depression, anxiety or neurodegenerative disease.

Dimocarpus longan, Dioscorea japonica and Houttuynia cordata are included as part of the broader traditional formula profile. Practitioner interest may include traditional use, antioxidant pathways, phytochemical research, cognitive performance research and general wellbeing contexts.

Because Schisandra has been discussed in relation to CYP450 and P-glycoprotein pathways, practitioners should consider medication use, pregnancy status and individual patient factors when recommending this product.

The above information is provided to support professional understanding of selected ingredients, traditional use and neurocognitive pathway research. It should not be used to promote CNS Factor / NeuroFactor for depression, treatment-resistant depression, anxiety, chronic stress disorder, cognitive impairment, neurodegenerative conditions, benzodiazepine withdrawal, SSRI support, neurotransmitter modulation, BDNF increase, GABA receptor modulation, cortisol hormone regulation or any other indication not included in the ARTG entry.

References available to registered practitioners on request.